Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Carl Zeiss Meditec AG - Filing #6525304

Concept 2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
As at
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2021-10-01 to
2022-09-30
2021-10-01 to
2022-09-30
2021-10-01 to
2022-09-30
2021-10-01 to
2022-09-30
2021-10-01 to
2022-09-30
2021-10-01 to
2022-09-30
2021-10-01 to
2022-09-30
As at
2022-09-30
2021-10-01 to
2022-09-30
2021-10-01 to
2022-09-30
Disclosure of effect of changes in foreign exchange rates [text block]
8
Foreign exchange gain (loss) [abstract]
Foreign exchange gain (loss)
38,202 EUR
48,630 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
1.121.197 EUR
1.030.964 EUR
Current assets
1.911.727 EUR
1.791.853 EUR
Non-current liabilities
298,375 EUR
253,410 EUR
Current liabilities
561,646 EUR
539,316 EUR
Revenue
2.089.300 EUR
1.902.836 EUR
Profit (loss)
290,396 EUR
290,396 EUR
0 EUR
0 EUR
1,613 EUR
0 EUR
0 EUR
292,009 EUR
0 EUR
0 EUR
2,002 EUR
293,909 EUR
0 EUR
293,909 EUR
0 EUR
0 EUR
295,911 EUR
0 EUR
Other comprehensive income
47,153 EUR
0 EUR
0 EUR
52,561 EUR
1,550 EUR
1,546 EUR
3,862 EUR
48,703 EUR
0 EUR
1,299 EUR
1,606 EUR
142,361 EUR
0 EUR
0 EUR
0 EUR
92,478 EUR
140,755 EUR
51,182 EUR
Comprehensive income
243,243 EUR
290,396 EUR
0 EUR
52,561 EUR
63,000 EUR
1,546 EUR
3,862 EUR
243,306 EUR
0 EUR
1,299 EUR
396,000 EUR
436,270 EUR
0 EUR
293,909 EUR
0 EUR
92,478 EUR
436,666 EUR
51,182 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.